| Literature DB >> 35449634 |
Farrukh Munir1, Hafiza Wajeeha Javaid1, Muhammad Burhan Majeed Rana2, Fatima Shaukat3.
Abstract
In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatment and patients can remain asymptomatic, frequent cell count monitoring is an essential tool to make a timely diagnosis. An appropriate drug switch, work up to rule out infection and granulocyte colony-stimulating factor (G-CSF) injection in high-risk cases is the management. The patient should be kept under observation till the resolution of agranulocytosis. We present a case of ceftriaxone-induced agranulocytosis which was completely reversible upon stoppage of drug and granulocyte colony-stimulating factor administration. The pathogenesis of ceftriaxone-induced agranulocytosis is unknown. It is suggested to occur either by an immunologic mechanism or because of direct drug toxicity.Entities:
Keywords: bone marrow biospy; ceftriaxone induced aganulocytosis; drug induced agranulocytosis; g-csf; neutropenia
Year: 2022 PMID: 35449634 PMCID: PMC9012477 DOI: 10.7759/cureus.23226
Source DB: PubMed Journal: Cureus ISSN: 2168-8184